Metformin Inflammation Study
STUDY BASICS
Are you a 55-85 years old UPMC patient who does NOT have diabetes? If so, you may be eligible to participate in a study to examine whether or not a medication called Metformin, a medication usually used to treat diabetes, improves the health of older adults. Study involves 6 visits, 5 blood samples, and 5 small stool samples to be mailed from home. Compensation including parking/bus pass provided.
IRB: STUDY19050193
- A Pilot Study: Metformin as an immune and inflammatory modulating therapy in older adults without diabetes.MEET THE RESEARCHER

Brian Zuckerbraun
Brian S. Zuckerbraun, MD, FACS, is Professor of Surgery and Chief of the Division of General/Trauma and Acute Care Surgery at the University of Pittsburgh. A graduate of Northwestern University, Dr. Zuckerbraun’s research interests include the protective responses within the liver that limit injury response to hemorrhage and sepsis as well as vascular injury and pulmonary arterial hypertension.